Medication Adherence and Non-adherence in Adults With Rare Disease
NCT04541875 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2022-05-12
Summary
The purpose of this study is to use the Medication Adherence Reasons Scale (MAR-Scale) to determine the extent of non-adherence to specific medications indicated to treat cystic fibrosis, hemophilia (A or B), idiopathic pulmonary fibrosis, myasthenia gravis, and sickle cell disease, and to identify the top patient-reported reasons for non-adherence. Internal reliability of the MAR-Scale will also be assessed in each condition.
Conditions
Interventions
- OTHER
-
MAR-Scale
The MAR-Scale is a 20-item questionnaire based on commonly reported reasons for non-adherence to medications.
Sponsors & Collaborators
-
The Touro College and University System
collaborator OTHER -
Xperiome
lead OTHER
Principal Investigators
-
Elizabeth J Unni, BpharmMBAPhD · Touro College of Pharmacy
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-01-31
- Primary Completion
- 2022-09-30
- Completion
- 2022-09-30
More Related Trials
-
Exploring Adherence Monitoring in Sickle Cell Disease
NCT03708731 ·Status: ACTIVE_NOT_RECRUITING
-
Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies
NCT01419704 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Study of MGTA-145 and Plerixafor in Patients With Sickle Cell Disease
NCT05445128 ·Status: TERMINATED ·Phase: PHASE2
-
Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507)
NCT03263559 ·Status: COMPLETED ·Phase: PHASE2
-
Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic Splenomegaly
NCT06743035 ·Status: RECRUITING
-
Integration of mHEALTH Into the Care of Patients With Sickle Cell Disease to Increase Hydroxyurea Utilization
NCT04080167 ·Status: COMPLETED ·Phase: NA
-
A Low-Interventional Study of an Electronic Sickle Cell Disease Patient Reported Outcomes in Sickle Cell Participants
NCT06503458 ·Status: TERMINATED
-
Patient Centered Comprehensive Medication Adherence Management System in Patients With Sickle Cell Disease
NCT02371720 ·Status: COMPLETED ·Phase: NA
-
Screening for Alpha Thalassemia in Healthy Volunteers
NCT02692872 ·Status: ACTIVE_NOT_RECRUITING
-
Adherence to Hydroxyurea in Children With Sickle Cell Anemia
NCT00672789 ·Status: COMPLETED ·Phase: NA
-
Gene Transfer for Patients With Sickle Cell Disease
NCT02186418 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Preventing Acute Chest Syndrome by Transfusion Feasibility Study
NCT00951808 ·Status: COMPLETED ·Phase: NA
-
Absorption, Metabolism, and Excretion of a Single Dose of Ferriprox® in Patients With Sickle Cell Disease
NCT01835496 ·Status: COMPLETED ·Phase: PHASE1
-
Medication Adherence in Youth With Sickle Cell Disease (SCD)
NCT02143076 ·Status: COMPLETED
-
Use of a Mobile-based App for SCD Patients
NCT01833702 ·Status: COMPLETED
-
Feasibility Study of Unfractionated Heparin in Acute Chest Syndrome
NCT02098993 ·Status: TERMINATED ·Phase: PHASE2
-
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat
NCT04610866 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity
NCT02435901 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Assessment of Opioid Analgesia in Sickle Cell
NCT00513864 ·Status: WITHDRAWN ·Phase: PHASE4
-
AB1 in Adult Patients with Sickle Cell Disease (SCD)
NCT05261711 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease
NCT04688411 ·Status: RECRUITING ·Phase: NA
-
The Longitudinal Relationship of HU Adherence to HRQOL, Barriers to Adherence and Habit in SCD.
NCT04691323 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody
NCT06358638 ·Status: RECRUITING ·Phase: PHASE2
-
Anticoagulation For Pulmonary Hypertension in Sickle Cell Disease
NCT01036802 ·Status: TERMINATED ·Phase: PHASE2
-
Haploidentical Hematopoietic Stem Cell Transplantation
NCT02165007 ·Status: COMPLETED ·Phase: PHASE1